4.8.2.5Vertical

Vascular Access & Therapy Devices

IV catheters, PICC lines, and venous access products.

Market snapshot

These figures describe Cardiovascular Devices (4.8.2), the segment that Vascular Access & Therapy Devices sits within. They are not figures for Vascular Access & Therapy Devices on its own.

Market size
~$40B
Growth
~3.7%CAGR (2017–22, nominal)
Companies
~780 firms
Firms by employee count

59.9% of firms have fewer than 20 employees: 467 micro-businesses, below most mandates.

The investable universe313 firms with 20+ employees
20–99
14847%
100–499
7223%
500+
9330%

~780 U.S. makers of pacemakers, defibrillators, stents, and structural-heart products, dominated by Medtronic, Abbott, Boston Scientific, and Edwards. Structural heart (TAVR) and electrophysiology are the growth frontiers; ~3.7%/yr overall. The federal code (electromedical apparatus) is broad, also spanning neuromodulation, so it captures more than cardiovascular alone.

NAICS 334510. U.S. Census Bureau, 2022 Statistics of U.S. Businesses; U.S. Census Bureau, 2022 Economic Census.

Business model & economics

Revenue model

Implant and device sales plus procedure-driven consumables

Key economics

Revenue per firm
$50,724,053
Revenue per employee
$416,677
Employees per firm
118.3
Recurring revenue
Moderate–High

procedure and replacement-driven

EBITDA margin
20–30%
Capex intensity
High

Characteristics

  • Balanced cost base: payroll is 26% of revenue, leaving room to scale margin without cutting staff
  • Moderate strategic-buyer pool: 93 firms exceed 500 employees, so a scaled asset has buyers, but not many
  • Structural heart (TAVR) and EP are the growth frontiers.
  • Aging demographics and minimally invasive shifts drive demand.
  • Dominated by Medtronic, Abbott, Boston Scientific, Edwards.

NAICS 334510. U.S. Census Bureau, 2022 Statistics of U.S. Businesses; U.S. Census Bureau, 2022 Economic Census.

M&A deal context

Deal activityHigh

Who’s acquiring

  • Cardiovascular-device strategics
  • Diversified medtech platforms
  • VC-backed innovators

What’s driving deals

  • Acquisition of structural-heart and EP innovation.
  • Aging-demographic and procedure-shift demand.
  • Pulsed-field ablation and next-gen EP competition.

Find Vascular Access & Therapy Devices acquisition targets

Search Acquisera’s index for companies classified under Vascular Access & Therapy Devices (4.8.2.5) and build a targeted deal pipeline.

Search companies